Home › Funds › TWO SIGMA ADVISERS, LP › BSX

TWO SIGMA ADVISERS, LP position in BSX

BOSTON SCIENTIFIC CORP · Health Care

TWO SIGMA ADVISERS, LP reported holding 6,298,460 shares of BSX (BOSTON SCIENTIFIC CORP) in its Q4 2025 13F filing — a position valued at US$600.6M, representing 1.17% of its reported portfolio and ranking #13 among its reported holdings. TWO SIGMA ADVISERS, LP has disclosed BSX holdings in 8 of the last 10 reported quarters, going back to Q3 2023.

Latest position (Q4 2025)6.30M sh
Reported value held$600.56M
Portfolio Weight1.17%
First reportedQ3 2023
Last changeAdd
Updated2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

How TWO SIGMA ADVISERS, LP's BSX position evolved

TWO SIGMA ADVISERS, LP first disclosed a stake in BSX in Q3 2023 at 337,660 shares (US$17.8M). The position peaked in Q4 2025 at 6,298,460 shares, worth US$600.6M. Across 8 filings, TWO SIGMA ADVISERS, LP increased the stake 6 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q4 2025) shows 6,298,460 shares valued at US$600.6M — an increase of 958,700 shares quarter over quarter.. Notable position changes include a 42% increase in Q3 2024 (shares rose 7% over the following quarter), a 49% increase in Q4 2024 (shares rose 13% over the following quarter), a 457% increase in Q1 2025 (shares rose 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 337.66K $17.83M New
Q2 2024 358.96K $27.64M New
Q3 2024 508.46K $42.61M Add
Q4 2024 755.26K $67.46M Add
Q1 2025 4.21M $424.30M Add
Q2 2025 5.17M $555.31M Add
Q3 2025 5.34M $521.32M Add
Q4 2025 6.30M $600.56M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BSX and 13F data

BSX (BOSTON SCIENTIFIC CORP) is a Health Care company. 20 other funds we track also report a position in BSX — the largest reported positions include Banque Cantonale Vaudoise (US$2.89B), PRIMECAP MANAGEMENT CO/CA/ (US$2.16B), D. E. Shaw & Co (US$1.16B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BSX

All BSX fund holders →

FAQ

How long has TWO SIGMA ADVISERS, LP held BSX?

TWO SIGMA ADVISERS, LP has disclosed BSX holdings in 8 of the last 10 reported quarters, going back to Q3 2023.

What is TWO SIGMA ADVISERS, LP's current position in BSX?

As of Q4 2025, TWO SIGMA ADVISERS, LP holds 6.30M shares of BSX (BOSTON SCIENTIFIC CORP), valued at $600.56M, representing 1.17% of its reported portfolio and ranking #13.

Has TWO SIGMA ADVISERS, LP been buying or selling BSX?

In the latest 13F filing (Q4 2025), TWO SIGMA ADVISERS, LP increased its position in BSX. The position peaked in Q4 2025 at 6.30M shares.

Which other funds hold BSX?

Other major institutional holders of BSX include Banque Cantonale Vaudoise, PRIMECAP MANAGEMENT CO/CA/, D. E. Shaw & Co, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.